Committee for Medicinal Products for Human Use

Results: 188



#Item
121Fax / European Organization for Rare Diseases / Science / Government / Technology / Agence française de sécurité sanitaire des produits de santé / Government of France

The European Agency for the Evaluation of Medicinal Products Pre-authorisation Evaluation of Medicines for Human Use CONTACT DETAILS OF PARTICIPANTS –COMMITTEE FOR ORPHAN MEDICINAL PRODUCTS (COMP) Members nominated by

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-10-09 09:11:53
122Bevacizumab / Ranibizumab / Angiology / Macular degeneration / Pharmaceutical industry / Vascular endothelial growth factor / Directorate-General for Health and Consumers / Committee for Medicinal Products for Human Use / Consumer organization / Medicine / Congress of Deputies / Health

Avastin vs Lucentis Letter sent to Vice-President Almunia on March 17th, 2014 Contact: Ilaria Passarani – [removed] Ref.: BEUC-X[removed]/2014

Add to Reading List

Source URL: www.beuc.org

Language: English - Date: 2014-03-18 12:19:39
123Research / Committee for Medicinal Products for Human Use / Health / Pharmaceutical sciences / Q / Pharmaceuticals policy / Quality by Design / Clinical research / Pharmaceutical industry / European Medicines Agency

Q9 Step 5 Cover page Quality risk management

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2014-05-28 11:00:20
124Pharmaceutical industry / Research / European Medicines Agency / Committee for Medicinal Products for Human Use / Validation / Moist heat sterilization / Sterilization / Guideline / Medical guideline / Medicine / Health / Clinical research

Concept Paper on the Revision of Sterilisation Processes Guidance - CVMP CHMP adoption final

Add to Reading List

Source URL: www.seikiken.or.jp

Language: English - Date: 2014-05-14 19:46:24
125Lenalidomide / European Medicines Agency / Health / Multiple myeloma / Committee for Medicinal Products for Human Use / Medicine / Immunosuppressants / Pharmacology

23 September 2011 EMA/CHMP[removed]Press Office Press release

Add to Reading List

Source URL: www.multiplesmyelom.at

Language: English - Date: 2011-10-14 03:30:20
126Anorectics / Organochlorides / Pyrazoles / Rimonabant / Organic chemistry / Pharmacology / European Medicines Agency / Committee for Medicinal Products for Human Use / Chemistry / Piperidines / Amides

European Medicines Agency Press office London, 23 October 2008 Doc. Ref. EMEA/CHMP[removed]

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2013-07-21 05:04:48
127Biology / Modafinil / Hypersomnia / Committee for Medicinal Products for Human Use / European Medicines Agency / Sleep / Narcolepsy / Shift work sleep disorder / Obstructive sleep apnea / Sleep disorders / Medicine / Health

Modafinil - Q&A - Art 31 referral FINAL_reexamination Nov 2010

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2013-07-21 06:08:55
128Drug safety / Clinical research / European Medicines Agency / Pharmaceutical industry / Committee for Medicinal Products for Human Use / Summary of Product Characteristics / Pharmacovigilance / Antipsychotic / Certolizumab pegol / Pharmaceutical sciences / Pharmacology / Health

23 January 2014 EMA/CHMP[removed]Committee for Medicinal Products for Human Use (CHMP) Summary of opinion 1 (initial authorisation)

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2014-01-24 07:02:26
129Lactams / Ergot / Ergoline / Ergoloid / Committee for Medicinal Products for Human Use / Dihydroergocristine / Dihydroergotamine / Nicergoline / European Medicines Agency / Organic chemistry / Lysergamides / Chemistry

Ergot derivatives_13.06_public health communication after re-examination for dihydroergotoxine

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2013-10-25 08:10:13
130Research / Pharmaceutical sciences / Health / Committee for Medicinal Products for Human Use / Directive 2001/83/EC / Summary of Product Characteristics / Medicinal product / European Medicines Agency / Pharmacology / Pharmaceuticals policy / Clinical research

Human Medicines - EMEA Pre-Submission Procedural Advice How will I know if the proposed invented name of my medicinal product is acceptable from a public health point of view? In accordance with Article 6 of Regulation (

Add to Reading List

Source URL: www.studioconsulenzabrevetti.it

Language: English - Date: 2008-06-27 10:21:48
UPDATE